Radiofrequency ablation (RFA): Clinical Trials

4 trials of Radiofrequency ablation (RFA), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 suspended. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Suspended 1

Follow Radiofrequency ablation (RFA): new trials by email Literature Review of Radiofrequency ablation (RFA) trials Research Report on Radiofrequency ablation (RFA)

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Synergism of Immunomodulation and Tumor Ablation
Durvalumab (MEDI4736), Tremelimumab, Sterotactic body radiation therapy (SBRT) - Colorectal Cancer, Liver Metastases
Phase 2CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC222018-11-232022-05-31
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)
Durvalumab, Tremelimumab, Trans-arterial Catheter Chemoembolization (TACE) - Biliary Tract Neoplasms, Liver Cancer
Phase 2CompletedNational Cancer Institute (NCI)542016-07-052023-03-28
Safety Study of Radiofrequency Ablation of Locally Advanced Pancreatic Cancer
radiofrequency ablation (RFA) - Locally Advanced Pancreatic Cancer
Phase 2CompletedUMC Utrecht172012-09-012015-02-02
Radiofrequency Ablation (RFA) Of Tumors Acquired In Childhood
Radiofrequency ablation (RFA) - Neoplasms, Benign, Neoplasms, Malignant
Phase 2SuspendedSeattle Children's Hospital602007-06-012009-09-01

Conditions studied

Bile Duct Neoplasms (1)  ·  Biliary Tract Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Cholangiocarcinoma (1)  ·  Colorectal Neoplasms (1)  ·  Diabetes Mellitus, Insulin-Dependent, 12 (1)  ·  Liver Neoplasms (1)  ·  Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  National Cancer Institute (NCI) (1)  ·  Seattle Children's Hospital (1)  ·  UMC Utrecht (1)

Countries

Netherlands (2)  ·  United States (2)  ·  Austria (1)  ·  France (1)  ·  Germany (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Fredric A Hoffer, MD (1)  ·  Jenny Seligmann (1)  ·  Richard van Hillegersberg, Professor (1)  ·  Theo Ruers (1)  ·  Tim F Greten, M.D. (1)

Results publications

PMID 38205877, PMID 39965889

NIH funding

2017 (1)